Cite
Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors
MLA
Sarah-Jane Dawson, et al. “Longitudinal Monitoring of CtDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 15, Dec. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c49a8579283e5bff46c36d6d7d64f038&authtype=sso&custid=ns315887.
APA
Sarah-Jane Dawson, Zeyad Al-Ogaili, Jenny H. Lee, Georgina V. Long, Elin S. Gray, Michael Millward, Shahneen Sandhu, Ashleigh C. McEvoy, Richard F. Kefford, Russell J. Diefenbach, Thien Tra, Richard A. Scolyer, Matteo S. Carlino, Stephen Q. Wong, Alexander M. Menzies, Alison Weppler, & Helen Rizos. (2019). Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 26(15).
Chicago
Sarah-Jane Dawson, Zeyad Al-Ogaili, Jenny H. Lee, Georgina V. Long, Elin S. Gray, Michael Millward, Shahneen Sandhu, et al. 2019. “Longitudinal Monitoring of CtDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26 (15). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c49a8579283e5bff46c36d6d7d64f038&authtype=sso&custid=ns315887.